Other languages NeoGenomics, Inc.

Equities

NEO

US64049M2098

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-31 pm EDT			5-day change	1st Jan Change
13.71 ^USD	-2.07%		-3.72%	-15.27%

May. 28	NeoGenomics, Inc. to Introduce Comprehensive Lung Solution & Feature Hematopathology Services At ASCO	CI
May. 02	North American Morning Briefing : Stock Futures -3-	DJ

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

NeoGenomics to Introduce Comprehensive Lung Solution and Feature Hematopathology Services at ASCO, Offering Actionable Insights to Support Treatment Management	May. 29
NeoGenomics to Introduce Comprehensive Lung Solution & Feature Hematopathology Services at ASCO, Offering Actionable Insights to Support Treatment Management	May. 28
NeoGenomics, Inc. to Introduce Comprehensive Lung Solution & Feature Hematopathology Services At ASCO	May. 28
North American Morning Briefing : Stock Futures -3-	May. 02
Needham Lowers Price Target on NeoGenomics to $19 From $24 Due to Peer Multiple Compression, Maintains Buy Rating	Apr. 30
Neogenomics Seeks M&A	Apr. 30
Transcript : NeoGenomics, Inc., Q1 2024 Earnings Call, Apr 30, 2024	Apr. 30
NeoGenomics: Q1 Earnings Snapshot	Apr. 30
Earnings Flash (NEO) NEOGENOMICS Reports Q1 Revenue $156.2M, vs. Street Est of $149.7M	Apr. 30
NeoGenomics Reports First Quarter 2024 Results	Apr. 30
NeoGenomics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 30
NeoGenomics, Inc. Reaffirms Consolidated Earnings Guidance for the Full Year 2024	Apr. 30
NeoGenomics Announces Senior Leadership Promotions	Apr. 18
NeoGenomics, Inc. Announces Senior Leadership Promotions	Apr. 18
NeoGenomics, Inc. Announces Eliminates of Position of Vishal Sikri, President, Advanced Diagnostics	Apr. 18
NeoGenomics to Report First Quarter 2024 Financial Results on April 30, 2024	Apr. 09
NeoGenomics Showcases Commitment to Transforming Cancer Patient Care at AACR 2024 Annual Meeting	Mar. 27
NeoGenomics Releases Inaugural Environmental, Social, and Governance (ESG) Report	Mar. 20
NeoGenomics to Participate in the TD Cowen 44th Annual Health Care Conference	Mar. 04
NeoGenomics to Participate in the TD Cowen 44th Annual Health Care Conference	Mar. 01

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages NeoGenomics, Inc.

Equities

NEO

US64049M2098

Other languages

Filters